Number of the records: 1  

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2

  1. TitleFundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
    Author Hudakova Nikola Kulkarni Amod SAVNEIMU - Neuroimunologický ústav SAV    ORCID

    Bhide Mangesh SAVNEIMU - Neuroimunologický ústav SAV    ORCID

    Kontseková Eva SAVNEIMU - Neuroimunologický ústav SAV    SCOPUS

    Čížková Dáša 1964 SAVNEIMU - Neuroimunologický ústav SAV    ORCID

    Co-authors Hricikova Simona
    Source document Pathogens. Vol. 10, no. 6 (2021), art. no. 636
    Languageeng - English
    CountryCH - Switzerland
    Document kindrozpis článkov z periodík (rbx)
    CitationsMARK, C. - GUPTA, S. - PUNNETT, A. - UPTON, J. - ORKIN, J. - ATKINSON, A. - CLARKE, L. - HEISEY, A. - MCGOVERN, C. - ALEXANDER, S. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. In PEDIATRIC BLOOD & CANCER. ISSN 1545-5009, NOV 2021, vol. 68, no. 11. Dostupné na: https://doi.org/10.1002/pbc.29295.
    CategoryADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2021
    Registered inWOS
    Registered inSCOPUS
    DOI 10.3390/pathogens10060636
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2.pdfavailable1.7 MB3Author's preprint
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    N
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    202120203.492Q20.984Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.